Bayer Poised To “Seize Opportunities” After Rapid Integration Of Roche OTCs
This article was originally published in The Tan Sheet
Executive Summary
Bayer will continue to pursue external as well as internal growth strategies for its OTC business following the rapid integration of Roche's OTC division
You may also be interested in...
Possible Statin-Parkinson’s Link To Be Explored In 16,000-Patient Study
Researchers at the University of North Carolina plan a 16,000-patient cohort study to explore a possible link between statin use and Parkinson's disease, expanding on their recent study linking low LDL cholesterol with the condition
Possible Statin-Parkinson’s Link To Be Explored In 16,000-Patient Study
Researchers at the University of North Carolina plan a 16,000-patient cohort study to explore a possible link between statin use and Parkinson's disease, expanding on their recent study linking low LDL cholesterol with the condition
Possible Statin-Parkinson’s Link To Be Explored In 16,000-Patient Study
Researchers at the University of North Carolina plan a 16,000-patient cohort study to explore a possible link between statin use and Parkinson's disease, expanding on their recent study linking low LDL cholesterol with the condition